Replimune Group Inc (REPL)
6.95
+0.39
(+5.95%)
USD |
NASDAQ |
May 03, 16:00
6.965
+0.02
(+0.22%)
After-Hours: 20:00
Replimune Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Esperion Therapeutics Inc | -0.5749 |
Gossamer Bio Inc | -- |
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 532.93M |
Total Liabilities (Quarterly) | 111.39M |
Shareholders Equity (Quarterly) | 421.54M |